New italian HCQ trial study results.

The use of hydroxycholoroquine + azithromycin was associated with a 66% reduction in risk of death as compared to controls; the analysis also suggested a larger effectiveness of hydroxychloroquine in patients with less severe COVID-19 disease

https://www.ijidonline.com/article/S1201-9712(20)30600-7/fulltext